ETO2-GLIS2

A Chimeric Transcription Factor Drives Leukemogenesis through a Neomorphic Transcription Network

Justin C. Wheat, Ulrich G. Steidl

Research output: Contribution to journalShort survey

Abstract

Acute megakaryoblastic leukemia (AMKL) is a heterogeneous disease with a relatively poorly understood pathogenesis. In this issue of Cancer Cell, Thirant and colleagues systematically examine unique transcriptional and functional effects of ETO2-GLIS2, an oncogenic fusion protein frequently encountered in AMKL, and elucidate a therapeutic vulnerability in this poor-prognosis leukemia.

Original languageEnglish (US)
Pages (from-to)307-308
Number of pages2
JournalCancer Cell
Volume31
Issue number3
DOIs
StatePublished - Mar 13 2017

Fingerprint

Leukemia, Megakaryoblastic, Acute
Transcription Factors
Leukemia
Neoplasms
Proteins
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Cell Biology
  • Cancer Research

Cite this

ETO2-GLIS2 : A Chimeric Transcription Factor Drives Leukemogenesis through a Neomorphic Transcription Network. / Wheat, Justin C.; Steidl, Ulrich G.

In: Cancer Cell, Vol. 31, No. 3, 13.03.2017, p. 307-308.

Research output: Contribution to journalShort survey

@article{c201af70231644efac5123e38b6f23c6,
title = "ETO2-GLIS2: A Chimeric Transcription Factor Drives Leukemogenesis through a Neomorphic Transcription Network",
abstract = "Acute megakaryoblastic leukemia (AMKL) is a heterogeneous disease with a relatively poorly understood pathogenesis. In this issue of Cancer Cell, Thirant and colleagues systematically examine unique transcriptional and functional effects of ETO2-GLIS2, an oncogenic fusion protein frequently encountered in AMKL, and elucidate a therapeutic vulnerability in this poor-prognosis leukemia.",
author = "Wheat, {Justin C.} and Steidl, {Ulrich G.}",
year = "2017",
month = "3",
day = "13",
doi = "10.1016/j.ccell.2017.02.015",
language = "English (US)",
volume = "31",
pages = "307--308",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "3",

}

TY - JOUR

T1 - ETO2-GLIS2

T2 - A Chimeric Transcription Factor Drives Leukemogenesis through a Neomorphic Transcription Network

AU - Wheat, Justin C.

AU - Steidl, Ulrich G.

PY - 2017/3/13

Y1 - 2017/3/13

N2 - Acute megakaryoblastic leukemia (AMKL) is a heterogeneous disease with a relatively poorly understood pathogenesis. In this issue of Cancer Cell, Thirant and colleagues systematically examine unique transcriptional and functional effects of ETO2-GLIS2, an oncogenic fusion protein frequently encountered in AMKL, and elucidate a therapeutic vulnerability in this poor-prognosis leukemia.

AB - Acute megakaryoblastic leukemia (AMKL) is a heterogeneous disease with a relatively poorly understood pathogenesis. In this issue of Cancer Cell, Thirant and colleagues systematically examine unique transcriptional and functional effects of ETO2-GLIS2, an oncogenic fusion protein frequently encountered in AMKL, and elucidate a therapeutic vulnerability in this poor-prognosis leukemia.

UR - http://www.scopus.com/inward/record.url?scp=85015100029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015100029&partnerID=8YFLogxK

U2 - 10.1016/j.ccell.2017.02.015

DO - 10.1016/j.ccell.2017.02.015

M3 - Short survey

VL - 31

SP - 307

EP - 308

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 3

ER -